VERTEX PHARMACEUTICALS INC / MA Unusual or Infrequent Item, or Both, Earnings Per Share Impact, Net
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Unusual or Infrequent Item, or Both, Earnings Per Share Impact, Net of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:UnusualOrInfrequentItemEarningsPerShareImpactNet · last filed 2016-02-16
- VERTEX PHARMACEUTICALS INC / MA unusual or infrequent item, or both, earnings per share impact, net for the quarter ending 2012-12-31 was -$0.25.
- VERTEX PHARMACEUTICALS INC / MA unusual or infrequent item, or both, earnings per share impact, net for the quarter ending 2012-06-30 was -$0.36.
- VERTEX PHARMACEUTICALS INC / MA unusual or infrequent item, or both, earnings per share impact, net for fiscal 2014 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA unusual or infrequent item, or both, earnings per share impact, net for fiscal 2013 was -$0.05.
- VERTEX PHARMACEUTICALS INC / MA unusual or infrequent item, or both, earnings per share impact, net for fiscal 2012 was -$0.61.
USD
| Period end | Unusual or Infrequent Item, or Both, Earnings Per Share Impact, Net 3 month | Unusual or Infrequent Item, or Both, Earnings Per Share Impact, Net 12 month |
|---|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-02-13 | |
| 2013-12-31 | -$0.05 10-K · filed 2016-02-16 | |
| 2012-12-31 | -$0.25 10-K · filed 2013-03-01 | -$0.61 10-K · filed 2015-02-13 |
| 2012-06-30 | -$0.36 10-K · filed 2013-03-01 |
USD/shares
| Period end | Unusual or Infrequent Item, or Both, Earnings Per Share Impact, Net 12 month |
|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-02-13 |
| 2013-12-31 | -$0.05 10-K · filed 2016-02-16 |
| 2012-12-31 | -$0.61 10-K · filed 2015-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |